Watermark Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Watermark Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$10K	Buy	+275	New	+$9.71K	﹤0.01%	171

Other funds holding TNDM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Watermark Asset Management's TNDM Position: Q4 2018 in Review

Watermark Asset Management opened a new position in Tandem Diabetes Care (TNDM) in Q4 2018: 275 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #171 among its holdings.

200 funds tracked by Wall St. Rank hold TNDM as of Q4 2018.

Watermark Asset Management held 275 shares of Tandem Diabetes Care worth $10K as of Q4 2018.
Tandem Diabetes Care was a new Watermark Asset Management position in Q4 2018.
Tandem Diabetes Care made up ﹤0.01% of Watermark Asset Management's portfolio in Q4 2018, its #171 holding.
200 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2018.

Based on Watermark Asset Management's 13F filing for Q4 2018, filed 14 Jan 2019.